Literature DB >> 34507636

Ginsenoside Rg1 promoted the wound healing in diabetic foot ulcers via miR-489-3p/Sirt1 axis.

Liang Huang1, Hua-An Cai2, Ming-Sheng Zhang3, Ruo-Yi Liao4, Xing Huang5, Feng-Dan Hu6.   

Abstract

PURPOSE: Diabetic foot ulcers (DFUs) are common complications of high severity for diabetes. Ginsenoside Rg1 (Rg1) has the potential for diabetes and cardiovascular diseases therapy. This research aimed at exploring the regulation of Rg1 on DFUs treatment and the underlying mechanism.
METHODS: Human umbilical vein endothelial cells (HUVECs) incubated with high-glucose culture medium were established for induction of diabetes model. The MTT assay, Annexin V/PI assay and oxidative stress detection were carried out on high-glucose-induced HUVECs. Dual-luciferase reporter assay was performed to prove the interaction of miR-489-3p and Sirt1. DFUs model was established to determine the efficiency of Rg1 and miR-489-3p in wound closure of DFUs in vivo.
RESULTS: Rg1 promoted cell proliferation, migration and angiogenesis, and reduced cell apoptosis in high-glucose-induced HUVECs. Knockdown of miR-489-3p alleviated the high-glucose-induced damage to HUVECs, while overexpression of miR-489-3p attenuated the protection effects of Rg1. Overexpression Sirt1 promoted wound healing in DFUs and Sirt1 was a direct target of miR-489-3p. In addition, animal experiments demonstrated that Rg1 promoted wound closure by regulating miR-489-3p/Sirt1 axis.
CONCLUSIONS: Rg1 alleviated the DFUs by increasing Sirt1 expression via miR-489-3p downregulation and promoting activation of PI3K/AKT/eNOS signaling.
Copyright © 2021 The Authors. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Diabetic foot ulcers; Ginsenoside Rg1; Sirt1; miR-489–3p

Mesh:

Substances:

Year:  2021        PMID: 34507636     DOI: 10.1016/j.jphs.2021.07.008

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  4 in total

1.  Ginsenoside Rg1 Mitigates Porcine Intestinal Tight Junction Disruptions Induced by LPS through the p38 MAPK/NLRP3 Inflammasome Pathway.

Authors:  Jian Kang; Yanhong Zhou; Chunyang Zhu; Tian Ren; Yong Zhang; Longfei Xiao; Binghu Fang
Journal:  Toxics       Date:  2022-05-27

2.  Ginsenoside Rg1 Suppresses Non-Small-Cell Lung Cancer via MicroRNA-126-PI3K-AKT-mTOR Pathway.

Authors:  Panfeng Chen; Xiaoping Li; Xi Yu; Min Yang
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-01       Impact factor: 2.650

3.  Expression Analysis of Moritella viscosa-Challenged Atlantic Salmon Identifies Disease-Responding Genes, MicroRNAs and Their Predicted Target Genes and Pathways.

Authors:  Sigmund Ramberg; Aleksei Krasnov; Duncan Colquhoun; Christian Wallace; Rune Andreassen
Journal:  Int J Mol Sci       Date:  2022-09-23       Impact factor: 6.208

4.  Ginsenoside Rg1 Inhibits STAT3 Expression by miR-15b-5p to Attenuate Lung Injury in Mice with Type 2 Diabetes Mellitus-Associated Pulmonary Tuberculosis.

Authors:  Tingxi Ma; Xiaohui Mao; Xiangguo Meng; Qinghu Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-04       Impact factor: 2.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.